These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10954208)

  • 1. Serum neopterin as an objective marker of psoriatic disease activity.
    Sánchez-Regaña M; Catasús M; Creus L; Umbert P
    Acta Derm Venereol; 2000 May; 80(3):185-7. PubMed ID: 10954208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of etanercept on urine neopterin levels in patients with psoriasis in a controlled, open-label study.
    Koc E; Tunca M; Akgul EO; Akar A; Kurt Y; Kurumlu Z; Erbil K; Kilic S
    J Dermatol; 2009 Apr; 36(4):191-6. PubMed ID: 19348656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased urine neopterin levels in psoriasis.
    Harland CC; Whitaker RP; Barron JL; Holden CA
    Br J Dermatol; 1992 Nov; 127(5):453-7. PubMed ID: 1467282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neopterin as a marker for immune system activation in coal workers' pneumoconiosis.
    Ulker OC; Yucesoy B; Durucu M; Karakaya A
    Toxicol Ind Health; 2007 Apr; 23(3):155-60. PubMed ID: 18220157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach in psoriasis: first usage of known protein oxidation markers to prove oxidative stress.
    Yazici C; Köse K; Utaş S; Tanrikulu E; Taşlidere N
    Arch Dermatol Res; 2016 Apr; 308(3):207-12. PubMed ID: 26842230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Neopterin Level and Disease Severity in Patients with Psoriasis Vulgaris Treated with Narrowband UVB.
    Kemeriz F; Gönül M; Cengiz FP; Emiroğlu N; Cemil BÇ
    Indian J Dermatol; 2019; 64(6):447-450. PubMed ID: 31896841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance of serum and urinary neopterin levels in several renal diseases.
    Lhee HY; Kim H; Joo KJ; Jung SS; Lee KB
    J Korean Med Sci; 2006 Aug; 21(4):678-82. PubMed ID: 16891812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between plasma neopterin and the urine neopterin:creatinine ratio as inflammatory biomarkers.
    Thomas B; Bipath P; Viljoen M
    Afr Health Sci; 2019 Sep; 19(3):2407-2413. PubMed ID: 32127811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neopterin as a new biomarker for the evaluation of occupational exposure to silica.
    Altindag ZZ; Baydar T; Isimer A; Sahin G
    Int Arch Occup Environ Health; 2003 May; 76(4):318-22. PubMed ID: 12768284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of parathyroid hormone and parathyroid-related peptide in psoriasis.
    Regaña MS; Ezquerra GM; Millet PU
    Acta Derm Venereol; 2005; 85(5):420-3. PubMed ID: 16159734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there any relationship between serum and urine neopterin and serum interferon-gamma levels in the activity of Behcet's disease?
    Erturan I; Basak PY; Ozturk O; Ceyhan AM; Akkaya VB
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1414-8. PubMed ID: 19522774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum YKL-40 as a potential biomarker of inflammation in psoriasis.
    Baran A; Myśliwiec H; Szterling-Jaworowska M; Kiluk P; Świderska M; Flisiak I
    J Dermatolog Treat; 2018 Feb; 29(1):19-23. PubMed ID: 28498006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of the neopterin in serum and urine of the patients with non-Hodgkin's lymphoma].
    Cheng XC; Li HC; Zhang R; Tan J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):443-6. PubMed ID: 15972138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a commercial urinary neopterin radioimmunoassay with high performance liquid chromatography.
    Hammerer-Lercher A; Moser C; Leichtfried V; Schobersberger W; Griesmacher A; Fuchs D
    Clin Chem Lab Med; 2012 Jan; 50(6):1075-8. PubMed ID: 22706249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cyclosporin A on immune activation markers in patients with active psoriasis.
    Economidou J; Barkis J; Demetriou Z; Avgerinou G; Psarra K; Degiannis D; Vareltzidis A; Katsambas A
    Dermatology; 1999; 199(2):144-8. PubMed ID: 10559581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels.
    Baran A; Świderska M; Myśliwiec H; Flisiak I
    J Dermatolog Treat; 2017 Mar; 28(2):136-140. PubMed ID: 27165470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40.
    Ataseven A; Kesli R
    G Ital Dermatol Venereol; 2016 Jun; 151(3):244-50. PubMed ID: 25279492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
    Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.
    Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Fiala Z
    Int J Dermatol; 2008 Aug; 47(8):800-5. PubMed ID: 18717859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neopterin concentrations in fetal and maternal blood: a marker of cell-mediated immune activation.
    Radunovic N; Kuczynski E; Rebarber A; Nastic D; Lockwood CJ
    Am J Obstet Gynecol; 1999 Jul; 181(1):170-3. PubMed ID: 10411815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.